AtriCure, Inc. ATRC 深 沪
等待开盘 04-01 09:30:00 美东时间
28.53
+0.270
+0.96%
华盛通- 最 高28.60
- 今 开28.49
- 成交量 47.03万股
- 最 低 27.45
- 昨 收 28.26
- 总市值 14.21亿
- 52周最高 43.18
- 市盈率 静 --
- 换手率 0.94%
- 52周最低 27.45
- 委 比 -91.46%
- 总股本 4980.99万
- 历史最高 89.18
- 量 比 1.16
- 振 幅 4.07%
- 历史最低 5.90
- 每 手 1
- 风险率 3.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
Oppenheimer Downgrades AtriCure to Perform
Oppenheimer analyst Suraj Kalia downgrades AtriCure (NASDAQ:ATRC) from Outperform to Perform.
02-18 19:39
电话会总结 ｜ AtriCure(ATRC)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据AtriCure业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 2025年全年总营收5.345亿美元，同比增长14.9%（按报告基准）和14.4%（按固定汇率基准） - 第四季度营收1.405亿美元，同比增长13.1%（按报告基准）和12.1%（按固定汇率基准） - 美国市场营收4.354亿美元，同比增长13.7% - 国际市场营收9920万美元，同比增长20.2%（按报告基准）和17.5%（按固定汇率基准） **盈利能力：** - 全年毛利率75%，较2024年提升29个基点 - 第四季度毛利率75%，较20
02-18 12:23
Update: AtriCure Sees FY2026 Adj EPS $0.09-$0.15 vs $(0.04) Est; Affirms FY2026 Sales Guidance of $600.000M-$610.000M vs $602.104M Est
AtriCure (NASDAQ:ATRC) is looking for FY2026 Adj EPS of $0.09-$0.15 vs $(0.04) analyst estimate. Affirms FY2026 sales outlook from $600.000 million-$610.000 million to $600.000 million-$610.000 million vs $602.104
02-18 05:59
AtriCure shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint above estimates.
AtriCure shares are trading higher after the company reported better-than-expec...
02-18 05:58
Earnings Scheduled For February 17, 2026
Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likel...
02-17 19:11
Insights into AtriCure's Upcoming Earnings
AtriCure (NASDAQ:ATRC) is set to give its latest quarterly earnings report on T...
02-17 04:01
美股大行评级 | AppLovin评级分歧大！高盛等4家下调，韦德布什上调；HubSpot、休曼纳公司、Shopify、Unity、Paycom Software等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从39美元升至47美元；HC Wainwright & Co.：维持Agios制药"买入"评级，目标价从62美元升至65美元
02-13 15:30
Needham Reiterates Buy on AtriCure, Maintains $45 Price Target
Needham analyst Mike Matson reiterates AtriCure (NASDAQ:ATRC) with a Buy and maintains $45 price target.
02-12 19:18
AtriCure shares are trading lower. The company announced preliminary Q4, FY25 financial results and issued FY26 financial guidance.
AtriCure shares are trading lower. The company announced preliminary Q4, FY25 f...
01-13 04:02
